DNTH vs TOST · rev $6.2M vs P/E 161, rev $4.96B
Dianthus Therapeutics Inc. (DNTH) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
DNTH currently screens at market cap $4.40B. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the DNTH and TOST stock pages for the full models.
Not investment advice.